CXXI Share Price Performance

CXXI Community Fair Values

RenovoRx
ST
Stock_Research_Today
Community Contributor
Revolutionizing Cancer Treatment
A Precision Approach to Hard-to-Treat Cancers RenovoRx, Inc. (Nasdaq: RNXT), based in Mountain View, California, is a clinical-stage biopharma company taking a new approach to cancer treatment.
View narrative
US$4.20
FV
66.2% undervalued intrinsic discount
371.30%
Revenue growth p.a.
11users have liked this narrative
0users have commented on this narrative
107users have followed this narrative
about 1 month ago author updated this narrative
Your Fair Value
CA$
Current Price
CA$0.2371.0% undervalued intrinsic discount
Growth estimate over
Annual revenue growth rate
%/yr
Decrease
Increase
Advanced

View all narratives

Recent CXXI News & Updates

Some C21 Investments Inc. (CSE:CXXI) Shareholders Look For Exit As Shares Take 26% Pounding

Nov 12

Subdued Growth No Barrier To C21 Investments Inc.'s (CSE:CXXI) Price

Sep 12

C21 Investments Inc. Competitors

View more competitors

Canadian Market Performance

1.0%

7.9%

15.8%

6.1%

The market has climbed 1.0% in the last 7 days, lead by the Materials sector with a gain of 3.7%. In contrast, the Healthcare sector is lagging, dropping 3.1%. In the last year, the market has climbed 16%. Looking forward, earnings are forecast to grow by 12% annually. Market details ›

C21 Investments Stock Price

CXXI Share Price Performance

CXXI Community Fair Values

Revolutionizing Cancer Treatment

Recent CXXI News & Updates

C21 Investments Inc. to Report Q4, 2025 Results on Jun 24, 2025

New major risk - Revenue and earnings growth

New major risk - Share price stability

Some C21 Investments Inc. (CSE:CXXI) Shareholders Look For Exit As Shares Take 26% Pounding

C21 Investments Inc. to Report Q2, 2025 Results on Nov 15, 2024

C21 Investments Inc., Annual General Meeting, Dec 06, 2024

Subdued Growth No Barrier To C21 Investments Inc.'s (CSE:CXXI) Price

Insufficient new directors

C21 Investments Inc. Competitors

🤖 A.I. Enters the “Show Me The Money” Phase

🧬 The Convergence of Genomic Medicine and AI Drug Discovery